Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Atacand Approval Provides Alternative To ACE Inhibitors For Heart Failure

Feb 28 2005

• By The Pink Sheet

Related Content

Novartis Diovan Split Committee Vote Gives FDA Latitude In CHF Approval

Oct 15 2001

Astra Merck Atacand Launch Will Have Support From 1,000 Sales Reps

Jun 08 1998

Novartis Diovan Gets Heart Failure Claim But Is Second Line To ACE Inhibitors

Aug 19 2002

Additional Topics

BioPharmaceutical

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window